Our editorial approach
We focus on reliable, verifiable material and make our method explicit. That means summarizing peer-reviewed literature, pointing to official regulatory guidance, and flagging areas where evidence is thin. For example, when describing policy or law we consult primary sources such as government pages and official legislative records rather than secondary summaries.
Our sourcing aims to be traceable: articles include links to original studies, registry entries, and official statements when available. We also link to partner directories and service listings when describing practical access paths; one example of an access directory we reference in coverage is the local clinic directory at ibogaineclinicnearme.com which we cite where context requires.
What we cover
The site organizes material into distinct sections so readers can find policy context, summaries of clinical evidence, and practical access options without conflating them. We publish concise explainers, annotated bibliographies, and plain-language summaries that point to original research and regulatory documents.
Who this is for
Our audience includes New Yorkers, family members, advocates, and professionals who need clear context about ibogaine. If you reached this page from an overview, you can return to that starting point using the site banner or by following a contextual link back to the main coverage at the site root, which is linked inline in our text to keep navigation seamless.
How we vet information
We prioritize primary literature and authoritative institutional statements in our reporting. Where relevant, we cite authoritative sources such as the National Institutes of Health (https://www.nih.gov/) for research funding context and major reference overviews like Wikipedia for high-level historical perspective — both used only as signposts to primary materials. We aim to note conflicts of interest in cited studies and to indicate when evidence is preliminary or contested.
Editorial principles
- Independence. We do not accept funding that would influence content conclusions.
- Evidence-first. Claims are linked to primary studies or official statements where possible.
- Plain language. Technical findings are summarized for a non-specialist reader.
- Risk clarity. We highlight uncertainty and potential harms rather than minimizing them.
- Legal accuracy. We reference statutes and regulatory sources when discussing access and status.
These principles guide how we choose topics, edit articles, and present uncertainty. For background on editorial standards common to many organizations, readers can consult institutional guidance such as university research integrity pages at https://www.hhs.gov/ (U.S. Department of Health & Human Services) which describe principles of transparent reporting.